Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Oxidative Medicine and Cellular Longevity|November 29, 2017
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline CardiotoxicityDonato Cappetta, Antonella De Angelis, Luigi Sapio, et al.
Cells|August 27, 2021
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and DiseaseDonato Cappetta, Oxana Bereshchenko, Eleonora Cianflone, et al.
Oncotarget|October 4, 2016
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in ratElena Piegari, Rosa Russo, Donato Cappetta, et al.
Cardio-Oncology (London, England)|February 3, 2021
Doxorubicin cardiotoxicity and target cells: a broader perspectiveAntonella De Angelis, Konrad Urbanek, Donato Cappetta, et al.
International Journal of Cardiology|January 6, 2016
SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathyDonato Cappetta, Grazia Esposito, Elena Piegari, et al.
Frontiers in Pharmacology|May 7, 2021
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello, et al.
Pharmacological Research|December 16, 2021
Current and future therapeutic perspective in chronic heart failureAnnamaria Mascolo, Gabriella di Mauro, Donato Cappetta, et al.
British Journal of Pharmacology|December 7, 2016
Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fractionGrazia Esposito, Donato Cappetta, Rosa Russo, et al.
Cardiovascular Diabetology|May 14, 2025
The effects of SGLT2i on cardiac metabolism in patients with HFpEF: Fact or fiction?Francesca Cinti, Renzo Laborante, Luigi Cappannoli, et al.
Pageof 7